文献速递关节外科

50岁及以下患者当代无菌性全髋关节翻修术:逾500例病例的结果

Contemporary Aseptic Revision Total Hip Arthroplasty in Patients ≤50 Years of Age: Results of >500 Cases.
PubMed 文献 · J Bone Joint Surg Am · 2024-04-30

研究纳入2000至2020年单中心545例50岁及以下患者无菌性全髋翻修术,平均随访10年。20年免再翻修生存率76%(95%CI 69%-82%),脱位、股骨假体无菌性松动和假体周围感染为最常见再翻修原因;以脱位为翻修指征者再翻修风险升高(HR 2.9,p<0.001)。

要点

  • 50岁及以下无菌性全髋翻修20年免再翻修生存率76%(95%CI 69%-82%)。
  • 脱位、股骨假体无菌性松动和假体周围感染为最常见再翻修原因。
  • 以脱位为翻修指征者再翻修风险升高(HR 2.9,p<0.001)。

核心结论

  • 当代50岁及以下患者无菌性全髋翻修术在20年时约每4例中有1例需再翻修。
  • 脱位、股骨假体无菌性松动和假体周围感染为最常见再翻修原因。
  • 以脱位为指征的翻修全髋关节置换术再翻修风险约高3倍。

研究设计与样本

  • 研究为单中心学术机构2000至2020年545例无菌性全髋翻修术的队列分析,患者年龄18至50岁。
  • 排除转换全髋关节置换术及任何同侧髋关节感染史患者;平均年龄43岁,平均BMI 29 kg/m²,63%为女性。
  • 翻修指征为无菌性松动46%、聚乙烯磨损或骨溶解28%(均为传统聚乙烯翻修)、脱位11%;126髋(23%)既往至少1次翻修(中位数1次,范围1至5次)。
  • 平均随访10年。

主要发现

  • 全队列20年免任何再翻修生存率76%(95%CI 69%至82%)。
  • 共87例再翻修,最常见原因为脱位31例、股骨假体无菌性松动18例、假体周围感染16例。
  • 以脱位为指征的翻修与再翻修风险升高相关(HR 2.9;p<0.001)。
  • 20年免任何再手术生存率73%(95%CI 66%至78%)。
  • 非手术并发症75例(14%),包括脱位32例;平均Harris髋关节评分从术前65显著改善至术后10年81(p<0.001)。

关键数值与推荐

  • 全队列20年免任何再翻修生存率76%(95%CI 69%至82%)。
  • 20年免任何再手术生存率73%(95%CI 66%至78%)。
  • 以脱位为翻修指征者再翻修风险HR 2.9(p<0.001)。
  • 平均Harris髋关节评分术前65改善至术后10年81(p<0.001)。
  • 证据等级:治疗性III级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been a paucity of long-term outcomes data on aseptic revision total hip arthroplasties (THAs) in the young adult population. The purpose of this study was to evaluate implant survivorship, complications, and clinical outcomes in a large cohort of contemporary aseptic revision THAs in patients ≤50 years of age at the time of the surgical procedure. METHODS: We identified 545 aseptic revision THAs performed at a single academic institution from 2000 to 2020 in patients who were 18 to 50 years of age. Patients who underwent conversion THAs and patients with a history of any ipsilateral hip infection were excluded. The mean age was 43 years, the mean body mass index (BMI) was 29 kg/m 2 , and 63% were female. The index indication for revision THA was aseptic loosening in 46% of cases, polyethylene wear or osteolysis in 28% of cases (all revisions of conventional polyethylene), and dislocation in 11% of cases. There were 126 hips (23%) that had undergone at least 1 previous revision (median, 1 revision [range, 1 to 5 revisions]). The mean follow-up was 10 years. RESULTS: In the entire cohort, the 20-year survivorship free of any re-revision was 76% (95% confidence interval [95% CI], 69% to 82%). There were 87 re-revisions, with 31 dislocations, 18 cases of aseptic loosening of the femoral component, and 16 periprosthetic joint infections (PJIs) being the most common reasons for re-revision. Dislocation as the indication for the index revision was associated with an increased risk of re-revision (hazard ratio, 2.9; p < 0.001). The 20-year survivorship free of any reoperation was 73% (95% CI, 66% to 78%). There were 75 nonoperative complications (14%), including 32 dislocations. The mean Harris hip score significantly improved (p < 0.001) from 65 preoperatively to 81 at 10 years postoperatively. CONCLUSIONS: Contemporary aseptic revision THAs in patients ≤50 years of age demonstrated a re-revision risk of approximately 1 in 4 at 20 years. Dislocation, aseptic loosening of the femoral component, and PJI were the most common reasons for re-revision. Index revision THAs for dislocation had a 3 times higher risk of re-revision. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Carender CN, Bothun CE, Sierra RJ, et al. Contemporary Aseptic Revision Total Hip Arthroplasty in Patients ≤50 Years of Age: Results of >500 Cases. J Bone Joint Surg Am. 2024. PMID: 38687829. doi:10.2106/JBJS.23.01467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。